Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 34.10
-0.50 (-1.45%)
At close: Nov 14, 2025
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 14.58 billion as of November 14, 2025. Its market cap has decreased by -3.26% in one year.
Market Cap
14.58B
Enterprise Value
17.52B
Revenue
5.71B
Ranking
n/a
PE Ratio
29.77
Stock Price
34.10
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 14.58B, an increase of 526.67%. That is a compound annual growth rate of 11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 14.58B | -4.08% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | 20.44B | -7.38% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.38T |
| Coloplast | 132.74B |
| Genmab | 120.27B |
| ALK-Abelló | 50.92B |
| Demant | 46.31B |
| H. Lundbeck | 42.99B |
| Zealand Pharma | 36.16B |
| Ambu A/S | 22.76B |